CTRI/2017/10/010272.

Study name	Comparing two types of chemotherapy in breast cancer
Methods	Accrual: not yet recruiting Accrual target: 268 Single‐centre, phase 2 RCT Trial is being conducted in India Blinding: not specified
Participants	People with stage 2 and 3 breast cancer Adjuvant or neoadjuvant: neoadjuvant
Interventions	Arm 1: intervention: docetaxel 75 mg/m2 day 1 and carboplatin AUC6 day 1 every 21 days for 6 cycles Arm 2: comparator: 5‐fluorouracil 500 mg/m2, epirubicin 100 mg/m2 and cyclophosphamide 500 mg/m2 day 1 every 21 days for 3 cycles followed by docetaxel 75 mg/m2 day 1 for 4 cycles
Outcomes	Primary Pathological complete response Secondary Objective tumour response Disease‐free survival Overall survival Adverse events
Starting date	Planned start date: 1 January 2017 Estimated completion date: not specified
Contact information	Contact: Biswajit Dubashi (drbiswajitdm@gmail.com)
Notes	Trial registration link: ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=20743 Trial sponsor: Jawaharlal Institute of Post Graduate Medical Education and Research Funding considerations: Jawaharlal Institute of Post Graduate Medical Education and Research, Puducherry